Century Therapeutics, Inc. (IPSC)
NASDAQ: IPSC · Real-Time Price · USD
1.040
+0.061 (6.19%)
At close: Dec 24, 2025, 4:00 PM EST
1.020
-0.020 (-1.92%)
After-hours: Dec 24, 2025, 4:44 PM EST
Century Therapeutics Market Cap
Century Therapeutics has a market cap or net worth of $90.81 million as of December 24, 2025. Its market cap has decreased by -27.35% in one year.
Market Cap
90.81M
Enterprise Value
2.14M
1-Year Change
-27.35%
Ranking
Category
Stock Price
$1.04
Market Cap Chart
Since the IPO on June 18, 2021, Century Therapeutics's market cap has decreased from $1.05B to $90.81M, a decrease of -91.36%. That is a compound annual growth rate of -41.82%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 24, 2025 | 90.81M | 5.74% |
| Dec 31, 2024 | 85.88M | -56.77% |
| Dec 29, 2023 | 198.65M | -34.34% |
| Dec 30, 2022 | 302.54M | -65.09% |
| Dec 31, 2021 | 866.61M | -17.54% |
| Jun 18, 2021 | 1.05B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 959.53B |
| Johnson & Johnson | 495.78B |
| AbbVie | 404.36B |
| UnitedHealth Group | 294.22B |
| AstraZeneca | 287.19B |
| Novartis AG | 267.64B |
| Merck & Co. | 260.71B |
| Novo Nordisk | 232.28B |